Profil
Stephen Lichaw is currently the Vice President-Business Development at Lirum Therapeutics, Inc. He previously worked as a Managing Director at Middlebury Securities LLC and as a Principal at Ladenburg Thalmann & Co., Inc. Mr. Lichaw holds an MBA from Cornell University and an undergraduate degree from the University of Hartford.
Postes actifs de Stephen Lichaw
| Sociétés | Poste | Début |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2022 |
Anciens postes connus de Stephen Lichaw
| Sociétés | Poste | Fin |
|---|---|---|
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Corporate Officer/Principal | - |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Private Equity Investor | - |
Formation de Stephen Lichaw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hartford
University of Hartford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ladenburg Thalmann & Co., Inc.
Ladenburg Thalmann & Co., Inc. Regional BanksFinance Provides investment baking, wealth management and brokerage services | Finance |
Middlebury Securities LLC
Middlebury Securities LLC Investment ManagersFinance Middlebury Securities invests in companies located in the United States. The firm focuses on life sciences sector. The firm participates in early stage capital funding and lending of structured debt. | Finance |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
















